Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cells
- 1 November 2002
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 139 (1) , 48-51
- https://doi.org/10.1016/s0165-4608(02)00604-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Peripheral-type benzodiazepine receptor levels correlate with the ability of human breast cancer MDA-MB-231 cell line to grow in scid miceInternational Journal of Cancer, 2001
- Structural and Functional Study of Reconstituted Peripheral Benzodiazepine ReceptorBiochemical and Biophysical Research Communications, 2001
- Amplification of oncogenes revisited: from expression profiling to clinical applicationCancer Letters, 2001
- Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptideProceedings of the National Academy of Sciences, 2001
- Relation of cell proliferation to expression of peripheral benzodiazepine receptors in human breast cancer cell linesBiochemical Pharmacology, 2000
- Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinomaLife Sciences, 1998
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Increase in ?3 (Peripheral-Type Benzodiazepine) binding site densities in different types of human brain tumoursActa Neurochirurgica, 1992
- Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovariesClinical Science, 1990
- Increase in Peripheral Benzodiazepine Binding Sites in Colonic AdenocarcinomaOncology, 1990